DE1492032U - - Google Patents

Info

Publication number
DE1492032U
DE1492032U DENDAT1492032D DE1492032DU DE1492032U DE 1492032 U DE1492032 U DE 1492032U DE NDAT1492032 D DENDAT1492032 D DE NDAT1492032D DE 1492032D U DE1492032D U DE 1492032DU DE 1492032 U DE1492032 U DE 1492032U
Authority
DE
Germany
Prior art keywords
iwt
iet
line
xtwllt
wteht
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1492032D
Other languages
German (de)
English (en)
Publication of DE1492032U publication Critical patent/DE1492032U/de
Active legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DENDAT1492032D Active DE1492032U (cg-RX-API-DMAC10.html)

Publications (1)

Publication Number Publication Date
DE1492032U true DE1492032U (cg-RX-API-DMAC10.html)

Family

ID=796683

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1492032D Active DE1492032U (cg-RX-API-DMAC10.html)

Country Status (1)

Country Link
DE (1) DE1492032U (cg-RX-API-DMAC10.html)

Similar Documents

Publication Publication Date Title
Berchick et al. Health insurance coverage in the United States: 2018
BARKER et al. Impact of epidemic type A influenza in a defined adult population
Karumbi et al. Directly observed therapy for treating tuberculosis
Fisher Mastodont procurement by Paleoindians of the Great Lakes region: hunting or scavenging?
Pinner et al. High cost nosocomial infections
Domingo-Salvany et al. Analytical considerations in the use of capture-recapture to estimate prevalence: case studies of the estimation of opiate use in the metropolitan area of Barcelona, Spain
Burr et al. Death after flumazepil
Holden Alcoholism and the Medical Cost Crunch: Researchers are trying to establish the cost-effectiveness of treatment for a disorder that is still largely a hidden burden on the health care system
Arnould et al. Do HMOs produce specific services more efficiently?
DE1492032U (cg-RX-API-DMAC10.html)
Laufer et al. Application of cost-effectiveness methodoloty tothe consideration of needlestick-prevention technology
Armstrong et al. Relative brain size and metabolism in birds
MORRISON JR et al. A MEASUREMENT OF THE EFFICACY OF NOSOCOMIAL INFECTION CONTROL USING TILE 95 PER CENT CONFIDENCE INTERVAL FOR INFECTION RATES
Kritchevsky et al. Impact of hospital care on incidence of bloodstream infection: the evaluation of processes and indicators in infection control study
Fibionisa et al. Comparison Analysis of Rates by Unit Cost and INA-CBGs Rates in Hemodialysis Services at Hospital X
Berkowitz et al. The Income-maintenance objective in workmen's compensation
Miller et al. A study of violent behaviors associated with cocaine use: Theoretical and pharmacological implications
Braathen et al. Autoimmune haemolytic anaemia associated with interferon alfa-2a in a patient with mycosis fungoides
Marín et al. An approach to fuzzy temporal reasoning in medicine
Shantz et al. State TANF Policies During the COVID-19 Pandemic: Work Requirements, Time Limits, and the Treatment of UI Income
Ellsworth Evaluating and applying information about treatment outcome
Jones et al. Agricultural Labor in the Southwest: The Post Bracero Years
Tongue Delays on Appeals to the Oregon Supreme Court
Ligon Fee-for-service versus HMO outpatient expenditure patterns
O'Brien et al. An economic evaluation of transdermal glyceryl trinitrate in the prevention of intravenous infusion failure